Alessandro Noseda
Direktor/Vorstandsmitglied bei REGENERX BIOPHARMACEUTICALS, INC.
Vermögen: - $ am 31.03.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| J. Finkelstein | M | 72 | 40 Jahre | |
| Allan L. Goldstein | M | 86 | 42 Jahre | |
| Marco Brughera | M | 70 |
Leadiant Biosciences SpA
 Leadiant Biosciences SpA Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Leadiant Biosciences SpA develops and manufactures pharmaceutical therapies for patients with rare diseases. The company is based in Rome, Italy. The Italian company was founded in 1957. Marco Maria Brughera has been the CEO of the company since 2011. Leadiant Biosciences was acquired by CHIESI Farmaceutici SpA on October 20, 2020.
University of Milan
| 17 Jahre |
| Joe McNay | M | 90 | 22 Jahre | |
| Mauro Bove | M | 69 | 20 Jahre | |
| R. Elsey | M | 71 | 14 Jahre | |
| Simon Miles Ball | M | 45 |
Leadiant Biosciences SpA
Leadiant Biosciences SpA Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Leadiant Biosciences SpA develops and manufactures pharmaceutical therapies for patients with rare diseases. The company is based in Rome, Italy. The Italian company was founded in 1957. Marco Maria Brughera has been the CEO of the company since 2011. Leadiant Biosciences was acquired by CHIESI Farmaceutici SpA on October 20, 2020.
Leadiant Biosciences, Inc.
 Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | - |
| Mike Ford | M | - |
Leadiant Biosciences SpA
Leadiant Biosciences SpA Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Leadiant Biosciences SpA develops and manufactures pharmaceutical therapies for patients with rare diseases. The company is based in Rome, Italy. The Italian company was founded in 1957. Marco Maria Brughera has been the CEO of the company since 2011. Leadiant Biosciences was acquired by CHIESI Farmaceutici SpA on October 20, 2020. | - |
| Taha Keilani | M | 67 |
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | 16 Jahre |
| Warren J. Holmes | M | - |
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | 23 Jahre |
| Gianfranco Fornasini | M | - |
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | 28 Jahre |
| Yamil O. Hernandez | M | - |
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | 25 Jahre |
| Nancy Klett | F | - |
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | 24 Jahre |
| Michael Minarich | M | - |
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | 8 Jahre |
| Andrea Dini | M | - |
Leadiant Biosciences SpA
Leadiant Biosciences SpA Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Leadiant Biosciences SpA develops and manufactures pharmaceutical therapies for patients with rare diseases. The company is based in Rome, Italy. The Italian company was founded in 1957. Marco Maria Brughera has been the CEO of the company since 2011. Leadiant Biosciences was acquired by CHIESI Farmaceutici SpA on October 20, 2020. | - |
| Raffaele Sanguigni | M | - |
Leadiant Biosciences SpA
Leadiant Biosciences SpA Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Leadiant Biosciences SpA develops and manufactures pharmaceutical therapies for patients with rare diseases. The company is based in Rome, Italy. The Italian company was founded in 1957. Marco Maria Brughera has been the CEO of the company since 2011. Leadiant Biosciences was acquired by CHIESI Farmaceutici SpA on October 20, 2020. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Gregg Lapointe | M | 65 |
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | 11 Jahre |
| David Lemus | M | 61 |
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | 4 Jahre |
| Danilo Penati | M | 60 |
University of Milan
| 4 Jahre |
| Giovanni Crespi | M | 65 |
University of Milan
| 4 Jahre |
| Valerio Verderio | M | - |
University of Milan
| 4 Jahre |
| Marco Levi | M | 64 |
University of Milan
| 4 Jahre |
| Ennio Bernasconi | M | - |
University of Milan
| 3 Jahre |
| Carlo Gandolfo Cerami | M | 59 |
University of Milan
| 4 Jahre |
| Guido Répaci | M | - |
University of Milan
| 4 Jahre |
| Christopher Lauderback | M | - |
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | 3 Jahre |
| Silvio Broggi | M | 61 |
University of Milan
| 4 Jahre |
| Marco Mortali | M | 66 |
University of Milan
| 4 Jahre |
| Massimo Bonomi | M | 66 |
University of Milan
| 3 Jahre |
| James Vincent Lambert | M | 60 |
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | 7 Jahre |
| Alberto Ferdinando Toffoletto | M | 63 |
University of Milan
| 3 Jahre |
| Carlo Persico | M | - |
University of Milan
| 4 Jahre |
| Luca Maria Rovere | M | - |
University of Milan
| 4 Jahre |
| Nicoletta Mastropietro | F | 61 |
University of Milan
| 4 Jahre |
| Roberto Lancellotti | M | 59 |
University of Milan
| 4 Jahre |
| Dario Moresco | M | 61 |
University of Milan
| 3 Jahre |
| Alfio Giorgio Gritti | M | 66 |
University of Milan
| 3 Jahre |
| Jean Pierre Seveke | M | 62 |
University of Milan
| 4 Jahre |
| Donatella Cungi | F | 63 |
University of Milan
| 3 Jahre |
| Carlo Brigada | M | 66 |
University of Milan
| 4 Jahre |
| Stefano Orfanini | M | - |
University of Milan
| 3 Jahre |
| Maria Grazia Filippini | F | 60 |
University of Milan
| 4 Jahre |
| Giorgio Calesella | M | 69 |
University of Milan
| 3 Jahre |
| Raven Jaeger | F | 46 |
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | 7 Jahre |
| Luca Minoli | M | 63 |
University of Milan
| 3 Jahre |
| Alessandro Malacart | M | 63 |
University of Milan
| 5 Jahre |
| Alberto Fioravanti | M | 62 |
University of Milan
| 9 Jahre |
| Paolo Melloni | M | 63 |
University of Milan
| 4 Jahre |
| Piero del Soldato | M | - |
University of Milan
| 4 Jahre |
| Giorgio Mosconi | M | 63 |
University of Milan
| 3 Jahre |
| Stefano Saccardi | M | 65 |
University of Milan
| 3 Jahre |
| Francesco Gardin | M | 69 |
University of Milan
| 30 Jahre |
| Andrea Rabusin | M | - |
University of Milan
| 4 Jahre |
| Bruno Gattai | M | 65 |
University of Milan
| 4 Jahre |
| Daniele Raynaud | M | 65 |
University of Milan
| 4 Jahre |
| Paolo Gavazzi | M | 77 |
University of Milan
| 9 Jahre |
| Enrico Colli | M | - |
University of Milan
| 3 Jahre |
| Alvise Sagramoso | M | 68 |
University of Milan
| 4 Jahre |
| Giacomo Foglia | M | 61 |
University of Milan
| 4 Jahre |
| Luciano Bonacorsi | M | - |
University of Milan
| 3 Jahre |
| Don DeLillo | M | - |
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | - |
| Luigi Fumagalli | M | 64 |
University of Milan
| 3 Jahre |
| Sergio Tamborini | M | 65 |
University of Milan
| 4 Jahre |
| Gianni Camisa | M | - |
University of Milan
| 4 Jahre |
| Luca Alippi | M | 61 |
University of Milan
| 4 Jahre |
| Wendy Perrow | F | 66 |
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | 3 Jahre |
| Andrea Costa | M | 64 |
University of Milan
| 4 Jahre |
| Nicla Picchi | F | 63 |
University of Milan
| 3 Jahre |
| Orio Bellezza | M | 65 |
University of Milan
| 4 Jahre |
| Filippo Gazzola | M | 60 |
University of Milan
| 3 Jahre |
| Giorgio Luca Bruno | M | 64 |
University of Milan
| 4 Jahre |
| Alessandro de Carli | M | - |
University of Milan
| 4 Jahre |
| Marc Tewey | M | - |
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | - |
| Stefano Gardi | M | - |
University of Milan
| 6 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Italien | 55 | 74,32% |
| Vereinigte Staaten | 20 | 27,03% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Alessandro Noseda
- Persönliches Netzwerk
